Gene therapy is emerging as one of the most promising frontiers, offering the possibility of correcting the root of disease instead of simply managing symptoms.<br /><br />At the heart of this effort is Bayer, the multinational pharmaceutical and biotechnology company investing heavily in emerging science through its subsidiaries AskBio and Viralgen, both based in San Sebastian, Spain.<br /><br />READ: https://mb.com.ph/2025/09/21/gene-therapy-brings-new-hope-for-those-suffering-from-heart-failure-parkinsons<br /><br />Join this channel to get access to perks: <br />https://www.youtube.com/channel/UC5664f6TkaeHgwBly50DWZQ/join <br /><br />Subscribe to the Manila Bulletin Online channel! - https://www.youtube.com/TheManilaBulletin <br /><br />Visit our website at http://mb.com.ph <br />Facebook: https://www.facebook.com/manilabulletin <br />Twitter: https://www.twitter.com/manila_bulletin <br />Instagram: https://instagram.com/manilabulletin <br />Tiktok: https://www.tiktok.com/@manilabulletin <br /><br />#ManilaBulletinOnline <br />#ManilaBulletin <br />#LatestNews
